Cargando…
A Randomised, Controlled Trial of Adjunctive Cholestyramine or Prednisolone Compared to Standard Therapy for the Treatment of Uncontrolled Graves’ Disease (the Chops Study)
Introduction: Antithyroid drugs (ATDs) are recommended effective treatment for uncontrolled Graves’ disease but achieves maximal antithyroid effects between 6 to 12 weeks. Cholestyramine sequesters thyroid hormones in the intestine and enhances its fecal excretion. Steroids inhibits the conversion o...
Autores principales: | Kim Khoo, Serena Sert, Hussein, Zanariah, Krishnan, Gayathri Devi, Tee, Hwee Ching, Chan, Pei Lin, Alias, Siti Aribah, Nor, Lisa Mohamed, Badarudin, Nurul Zaidah, Valayatham, Vijiya Mala, Fung, Yin Khet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090393/ http://dx.doi.org/10.1210/jendso/bvab048.1677 |
Ejemplares similares
-
SAT483 Role of Cholestyramine in Refractory Amiodarone-induced Thyrotoxicosis
por: Zhao, Huaying, et al.
Publicado: (2023) -
SUN-492 Treatment of Uncontrolled Graves’ Disease Reveals Underlying Thyroiditis
por: Sheung, Nicole, et al.
Publicado: (2020) -
SAT474 A Case Report Of Moyamoya Disease Associated With Uncontrolled Graves' Disease
por: Tan, Zi, et al.
Publicado: (2023) -
Recurrent Severe Hypoglycemia Secondary to Benign Phyllodes Tumor of the Breast: A Rare Case of Non-Islet Cell Tumor-induced Hypoglycemia (NICTH)
por: Tee, Hwee Ching, et al.
Publicado: (2021) -
A Grave Initial Presentation of Graves’ Disease in a Patient With Moyamoya
por: Clutter, Courtney, et al.
Publicado: (2021)